165
Views
9
CrossRef citations to date
0
Altmetric
Review

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

, , &
Pages 785-797 | Published online: 15 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2018) Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how. Expert Review of Respiratory Medicine 12:4, pages 261-264.
Read now
Amnon Ariel, Alan Altraja, Andrey Belevskiy, Piotr W Boros, Edvardas Danila, Matjaz Fležar, Vladimir Koblizek, Zvi G Fridlender, Kosta Kostov, Alvils Krams, Branislava Milenkovic, Attila Somfay, Ruzena Tkacova, Neven Tudoric, Ruxandra Ulmeanu & Arschang Valipour. (2018) Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 45-56.
Read now
Jose Luis Lopez-Campos, Carmen Calero-Acuña, Eduardo Márquez-Martín, Esther Quintana Gallego, Laura Carrasco-Hernández, Maria Abad Arranz & Francisco Ortega Ruiz. (2017) Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1867-1876.
Read now
Douglas Mapel, François Laliberté, Melissa H Roberts, Susan R Sama, Devi Sundaresan, Dominic Pilon, Patrick Lefebvre, Mei Sheng Duh & Jeetvan Patel. (2017) A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1825-1836.
Read now
Klaus F. Rabe. (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Review of Clinical Pharmacology 10:7, pages 685-698.
Read now

Articles from other publishers (4)

Lai Wei, Yujing Wang & Yuyun Zhao. (2022) Combination Therapy for COPD: Efficacy and Prospects of Multiple Therapy. Highlights in Science, Engineering and Technology 8, pages 64-68.
Crossref
E. A. Orlova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2022) The double bronchodilation era: new capabilities in a new drug delivery device. Meditsinskiy sovet = Medical Council:4, pages 128-137.
Crossref
Albino Petrone, Filippo Luca Fimognari, Francesco Mormile, Leonello Fuso, Michela Quartieri, Ludovico Petrone & Francesco Romano. (2018) Das respiratorische «Overlap-Syndrom»: Wirksamkeit und Nutzen der kombinierten zweifachen Bronchodilatation. Kompass Pneumologie 6:4, pages 259-262.
Crossref
A. A. Vizel' & I. Yu. Vizel'. (2016) DuoResp Spiromax® is a new intuitive dosing dry powder inhaler of budesonide and formoterol. PULMONOLOGIYA 26:4, pages 498-504.
Crossref